Modeling autonomic regulation of cardiac function and heart rate variability in human endotoxemia

Physiological Genomics

Volumn 43, Issue 16, 2011, Pages 951-964

  Scheff, Jeremy D ^a   Mavroudis, Panteleimon D ^b   Calvano, Steven E ^c   Lowry, Stephen F ^c   Androulakis, Ioannis P ^a,b,c  

^a RUTGERS UNIVERSITY   (United States)

^b The State University of New Jersey   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Circadian; Inflammation; Systems biology

Indexed keywords

ACUTE STRESS; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CIRCADIAN RHYTHM; ENDOTOXEMIA; HEART BEAT; HEART FUNCTION; HEART RATE VARIABILITY; HOMEOSTASIS; MATHEMATICAL MODEL; OSCILLATOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

ENDOTOXEMIA; HEART RATE; HUMANS; MODELS, THEORETICAL; SYSTEMS BIOLOGY;

EID: 80052072238     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00040.2011     Document Type: Article

References (85)

1. Almon RR, DuBois DC, Brandenburg EH, Shi W, Zhang S, Straubinger RM, Jusko WJ. Pharmacodynamics and pharmacogenomics of diverse receptor-mediated effects of methylprednisolone in rats using microarray analysis. J Pharmacokinet Pharmacodyn 29: 103-129, 2002.
2. Almon RR, Dubois DC, Jin JY, Jusko WJ. Pharmacogenomic responses of rat liver to methylprednisolone: an approach to mining a rich microarray time series. Aaps J 7: E156-E194, 2005.
3. Almon RR, DuBois DC, Jusko WJ. A microarray analysis of the temporal response of liver to methylprednisolone: a comparative analysis of two dosing regimens. Endocrinology 148: 2209-2225, 2007.
4. Almon RR, Lai W, DuBois DC, Jusko WJ. Corticosteroid-regulated genes in rat kidney: mining time series array data. Am J Physiol Endocrinol Metab 289: E870-E882, 2005.
5. Alvarez SM, Katsamanis Karavidas M, Coyle SM, Lu SE, Macor M, Oikawa LO, Lehrer PM, Calvano SE, Lowry SF. Low-dose steroid alters in vivo endotoxin-induced systemic inflammation but does not influence autonomic dysfunction. J Endotoxin Res 13: 358-368, 2007.
6. Andreasen AS, Krabbe KS, Krogh-Madsen R, Taudorf S, Pedersen BK, Moller K. Human endotoxemia as a model of systemic inflammation. Curr Med Chem 15: 1697-1705, 2008.
7. Bayly EJ. Spectral analysis of pulse frequency modulation in the nervous systems. IEEE Trans Biomed Eng 15: 257-265, 1968.
8. Bayston KF, Cohen J. Bacterial endotoxin and current concepts in the diagnosis and treatment of endotoxaemia. J Med Microbiol 31: 73-83, 1990.
9. Brennan M, Palaniswami M, Kamen P. Do existing measures of Poincare plot geometry reflect nonlinear features of heart rate variability? IEEE Trans Biomed Eng 48: 1342-1347, 2001.
10. Brennan M, Palaniswami M, Kamen P. Poincare plot interpretation using a physiological model of HRV based on a network of oscillators. Am J Physiol Heart Circ Physiol 283: H1873-H1886, 2002.
11. Buchman TG. The digital patient: predicting physiologic dynamics with mathematical models. Crit Care Med 37: 1167-1168, 2009.
12. Buchman TG. Physiologic stability and physiologic state. J Trauma 41: 599-605, 1996.
13. Burger AJ, Charlamb M, Sherman HB. Circadian patterns of heart rate variability in normals, chronic stable angina and diabetes mellitus. Int J Cardiol 71: 41-48, 1999.
14. Burgess HJ, Trinder J, Kim Y, Luke D. Sleep and circadian influences on cardiac autonomic nervous system activity. Am J Physiol Heart Circ Physiol 273: H1761-H1768, 1997.
15. Buttenschoen K, Kornmann M, Berger D, Leder G, Beger HG, Vasilescu C. Endotoxemia and endotoxin tolerance in patients with ARDS. Langenbecks Arch Surg 393: 473-478, 2008.
16. Chiu HW, Kao T. A mathematical model for autonomic control of heart rate variation. IEEE Eng Med Biol Mag 20: 69-76, 2001.
17. Dimitrov S, Benedict C, Heutling D, Westermann J, Born J, Lange T. Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. Blood 113: 5134-5143, 2009.
18. DuBois DC, Xu ZX, McKay L, Almon RR, Pyszcznski N, Jusko WJ. Differential dynamics of receptor down-regulation and tyrosine aminotransferase induction following glucocorticoid treatment. J Steroid Biochem Mol Biol 54: 237-243, 1995.
19. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52: 595-638, 2000.
20. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. In silico simulation of corticosteroids effect on an NFkB-dependent physicochemical model of systemic inflammation. PLoS One 4: e4706, 2009.
21. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. Modeling endotoxin-induced systemic inflammation using an indirect response approach. Math Biosci 217: 27-42, 2009.
22. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. Multiscale model for the assessment of autonomic dysfunction in human endotoxemia. Physiol Genomics 42: 5-19, 2010.
23. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. A physiological model for autonomic heart rate regulation in human endotoxemia. Shock 35: 229-239, 2011.
24. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. Translational potential of systems-based models of inflammation. Clin Transl Sci 2: 85-89, 2009.
25. Freeman BD, Natanson C. Anti-inflammatory therapies in sepsis and septic shock. Expert Opin Investig Drugs 9: 1651-1663, 2000.
26. Gherghel D, Hosking SL, Orgul S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol 49: 491-508, 2004.
27. Godin PJ, Buchman TG. Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 24: 1107-1116, 1996.
28. Godin PJ, Fleisher LA, Eidsath A, Vandivier RW, Preas HL, Banks SM, Buchman TG, Suffredini AF. Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trial. Crit Care Med 24: 1117-1124, 1996.
29. Haimovich B, Calvano J, Haimovich AD, Calvano SE, Coyle SM, Lowry SF. In vivo endotoxin synchronizes and suppresses clock gene expression in human peripheral blood leukocytes. Crit Care Med 38: 751-758, 2010.
30. Haimovich B, Reddell MT, Calvano JE, Calvano SE, Macor MM, Coyle SM, Lowry SF. A novel model of common Toll-like receptor 4-and injury-induced transcriptional themes in human leukocytes. Crit Care 14: R177, 2010
31. Hazra A, Pyszczynski N, DuBois DC, Almon RA, Jusko WJ. Modeling receptor/gene-mediated effects of corticosteroids on hepatic tyrosine aminotransferase dynamics in rats: dual regulation by endogenous and exogenous corticosteroids. J Pharmacokin Pharmacodyn 34: 643-667, 2007.
32. Hrushesky WJM, Langevin T, Kim YJ, Wood PA. Circadian dynamics of tumor-necrosis-factor-alpha (cachectin) lethality. J Exp Med 180: 1059-1065, 1994.
33. Hrushesky WJM, Wood PA. Circadian time structure of septic shock: Timing is everything. J Infect Dis 175: 1283-1284, 1997.
34. Huikuri HV, Niemela MJ, Ojala S, Rantala A, Ikaheimo MJ, Airaksinen KE. Circadian rhythms of frequency domain measures of heart rate variability in healthy subjects and patients with coronary artery disease. Effects of arousal and upright posture. Circulation 90: 121-126, 1994.
35. Ihekwaba AE, Broomhead DS, Grimley RL, Benson N, Kell DB. Sensitivity analysis of parameters controlling oscillatory signalling in the NF-kappaB pathway: the roles of IKK and IkappaBalpha. Syst Biol (Stevenage) 1: 93-103, 2004.
36. Jan BU, Coyle SM, Macor MA, Reddell M, Calvano SE, Lowry SF. Relationship of basal heart rate variability to in vivo cytokine responses after endotoxin exposure. Shock 33: 363-368, 2010.
37. Jan BU, Coyle SM, Oikawa LO, Lu SE, Calvano SE, Lehrer PM, Lowry SF. Influence of acute epinephrine infusion on endotoxin-induced parameters of heart rate variability: a randomized controlled trial. Ann Surg 249: 750-756, 2009.
38. Javorka M, Zila I, Balharek T, Javorka K. Heart rate recovery after exercise: relations to heart rate variability and complexity. Braz J Med Biol Res 35: 991-1000, 2002.
39. Jin JY, Almon RR, DuBois DC, Jusko WJ. Modeling of corticosteroid pharmacogenomics in rat liver using gene microarrays. J Pharmacol Exp Ther 307: 93-109, 2003.
40. Jusko WJ. Receptor-mediated pharmacodynamics of corticosteroids. Prog Clin Biol Res 387: 261-270, 1994.
41. Karemaker JM. Autonomic integration: the physiological basis of cardiovascular variability. J Physiol 517: 316, 1999.
42. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59: 256-262, 1987.
43. Korpelainen JT, Sotaniemi KA, Huikuri HV, Myllyla VV. Circadian rhythm of heart rate variability is reversibly abolished in ischemic stroke. Stroke 28: 2150-2154, 1997.
44. Kronfol Z, Nair M, Zhang Q, Hill EE, Brown MB. Circadian immune measures in healthy volunteers: relationship to hypothalamic-pituitaryadrenal axis hormones and sympathetic neurotransmitters. Psychosom Med 59: 42-50, 1997.
45. Lahiri MK, Kannankeril PJ, Goldberger JJ. Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol 51: 1725-1733, 2008.
46. Lake DE, Richman JS, Griffin MP, Moorman JR. Sample entropy analysis of neonatal heart rate variability. Am J Physiol Regul Integr Comp Physiol 283: R789-R797, 2002.
47. Lombardi F, Malliani A, Pagani M, Cerutti S. Heart rate variability and its sympatho-vagal modulation. Cardiovasc Res 32: 208-216, 1996.
48. Lowry SF. Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock 24, Suppl 1: 94-100, 2005.
49. Lowry SF. The stressed host response to infection: the disruptive signals and rhythms of systemic inflammation. Surg Clin North Am 89: 311-326 2009.
50. Lowry SF, Calvano SE. Challenges for modeling and interpreting the complex biology of severe injury and inflammation. J Leukoc Biol 83: 553-557, 2008.
51. Miyata T, Torisu M. Plasma endotoxin levels and functions of peripheral granulocytes in surgical patients with respiratory distress syndrome. Jpn J Surg 16: 412-417, 1986.
52. Morris JA Jr, Norris PR, Waitman LR, Ozdas A, Guillamondegui OD, and Jenkins JM. Adrenal insufficiency, heart rate variability, and complex biologic systems: a study of 1,871 critically ill trauma patients. J Am Coll Surg 204: 885-892, 2007.
53. Nakagawa M, Iwao T, Ishida S, Yonemochi H, Fujino T, Saikawa T, Ito M. Circadian rhythm of the signal averaged electrocardiogram and its relation to heart rate variability in healthy subjects. Heart 79: 493-496, 1998.
54. Nakao M, Norimatsu M, Mizutani Y, Yamamoto M. Spectral distortion properties of the integral pulse frequency modulation model. IEEE Trans Biomed Eng 44: 419-426, 1997.
55. Niklasson U, Wiklund U, Bjerle P, Olofsson BO. Heart-rate variation: what are we measuring? Clin Physiol 13: 71-79, 1993.
56. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 117: 1162-1172, 2000.
57. Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180: 1584-1589, 1999.
58. Pagani M. Heart rate variability and autonomic diabetic neuropathy. Diabetes Nutr Metab 13: 341-346, 2000.
59. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471-1477, 1993.
60. Peng CK, Havlin S, Stanley HE, Goldberger AL. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos 5: 82-87, 1995.
61. Petrovsky N, Harrison LC. The chronobiology of human cytokine production. Int Rev Immunol 16: 635-649, 1998.
62. Pincus SM. Greater signal regularity may indicate increased system isolation. Math Biosci 122: 161-181, 1994.
63. Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S, Webb-Peploe K, Harrington D, Banasiak W, Wrabec K, Coats AJ. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 79: 1645-1650, 1997.
64. Ramakrishnan R, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ. Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats. J Pharmacokinet Pharmacodyn 29: 1-24, 2002.
65. Rassias AJ, Holzberger PT, Givan AL, Fahrner SL, Yeager MP. Decreased physiologic variability as a generalized response to human endotoxemia. Crit Care Med 33: 512-519, 2005.
66. Richman JS, Moorman JR. Physiological time-series analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol 278: H2039-H2049, 2000.
67. Saito Y, Shimizu T, Takahashi Y, Mishima K, Takahashi K, Ogawa Y, Kogawa S, Hishikawa Y. Effect of bright light exposure on muscle sympathetic nerve activity in human. Neurosci Lett 219: 135-137, 1996.
68. Sayk F, Vietheer A, Schaaf B, Wellhoener P, Weitz G, Lehnert H, Dodt C. Endotoxemia causes central downregulation of sympathetic vasomotor tone in healthy humans. Am J Physiol Regul Integr Comp Physiol 295: R891-R898, 2008.
69. Schaller MD, Waeber B, Nussberger J, Brunner HR. Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. Am J Physiol Heart Circ Physiol 249: H1086-H1092, 1985.
70. Scheff JD, Calvano SE, Lowry SF, Androulakis IP. Modeling the influence of circadian rhythms on the acute inflammatory response. J Theor Biol 264: 1068-1076, 2010.
71. Schmidt H, Müller-Werdan U, Werdan K. Autonomic dysfunction: A relevant component in multiple organ dysfunction syndrome. In: Yearbook of Intensive Care and Emergency Medicine, edited by Vincent JL. Berlin: Springer, 2007, p. 455-467.
72. Seely AJ, Christou NV. Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 28: 2193-2200, 2000.
73. Shanker BA, Coyle SM, Reddell MT, Choi CW, Calvano J, Macor MA, Calvano SE, Lowry SF. Modeling the human injury response. J Am Coll Surg 211: S53-S54, 2010.
74. Sternberg EM. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 6: 318-328, 2006.
75. Sun YN, DuBois DC, Almon RR, Jusko WJ. Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver. J Pharmacokinet Biopharm 26: 289-317, 1998.
76. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93: 1043-1065, 1996.
77. van der Poll T. Effects of catecholamines on the inflammatory response. Sepsis 4: 159-167, 2001.
78. van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 97: 713-719, 1996.
79. Vodovotz Y. Translational systems biology of inflammation and healing. Wound Repair Regen 18: 3-7, 2010.
80. Vodovotz Y, Clermont G, Chow C, An G. Mathematical models of the acute inflammatory response. Curr Opin Crit Care 10: 383-390, 2004.
81. Vodovotz Y, Constantine G, Rubin J, Csete M, Voit EO, An G. Mechanistic simulations of inflammation: current state and future prospects. Math Biosci 217: 1-10, 2009.
82. Vodovotz Y, Csete M, Bartels J, Chang S, An G. Translational systems biology of inflammation. PLoS Comput Biol 4: e1000014, 2008.
83. Warner HR, Cox A. A mathematical model of heart rate control by sympathetic and vagus efferent information. J Appl Physiol 17: 349-355, 1962.
84. Wurtman RJ, Pohorecky LA, Baliga BS. Adrenocortical control of the biosynthesis of epinephrine and proteins in the adrenal medulla. Pharmacol Rev 24: 411-426, 1972.
85. Xu ZX, Sun YN, DuBois DC, Almon RR, Jusko WJ. Third-generation model for corticosteroid pharmacodynamics: roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver. J Pharmacokinet Biopharm 23: 163-181, 1995